Animal-health company Zoetis Inc. said its fourth-quarter earnings rose 20% on stronger revenue, and expects new pet drugs to fuel future sales growth despite a stronger dollar.
Zoetis, which was spun off by pharmaceutical company Pfizer Inc. in 2013, is the world’s leading seller of vaccines and medicines for livestock and household pets by sales.
Zoetis is generally eyeing the roughly $9 billion companion-animal market for growth, Zoetis Chief Executive Juan Ramon Alaix said.
- Forums
- ASX - By Stock
- AN1
- Zoetis and Animal Health
Zoetis and Animal Health, page-2
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable